Interviews

Proven medical device and health technology experts will show you how to improve your sales & marketing efforts, enhance your regulatory submissions, raise venture capital, and much more.

Latest

Check out the most recent interviews with world-class medical device and health technology founders and CEOs.

Go Premium
Premium

Nothing Matters as Much as Execution and Iteration

Interview with Wyndly CEO Aakash Shah

Wyndly is a telehealth company that helps people overcome their allergies with personalized treatment plans that can be followed from home. In this interview, CEO Aakash Shah shares insights on simplifying healthcare access by meeting patients online and emphasizes the importance of learning by doing to accelerate personal and business growth. Aakash also talks about the power of storytelling when engaging customers and investors, and of how to leverage video-based social media to reach both consumers and decision-makers effectively.

Premium

Finding Opportunities When Curveballs Come Your Way

Interview with Cytovale CEO Ajay Shah

Ajay Shah, co-founder and CEO of Cytovale, is aiming to help solve the sepsis problem with IntelliSep, a simple, cost-effective, and quick sepsis test. In this interview, Ajay shares why CEOs should immerse themselves in the problem they’re hoping to tackle, how he nurtures relationships with investors over time, and his opinions on making the transition to entrepreneurship from a non-commercial career path.

Premium

Identifying and Mitigating Key Risk Factors in Medtech Startups

Interview with Adona Medical CEO Brian Fahey

Brian Fahey, CEO of Adona Medical, is leading the development of the Adona Interatrial Shunt, a smart implant designed to manage heart failure. This adjustable shunt, integrated with bi-atrial pressure monitoring, helps regulate blood flow between the heart's upper chambers and enables remote monitoring of patients. In this interview, Brian talks about the importance of identifying and mitigating medtech’s three major risk factors, how to assess ideas strategically, and how to approach investors and potential M&A transactions.

Premium

De-Risking Your Way to a Successful Fundraise

Interview with WearLinq CEO Konrad Morzkowski

Konrad Morzkowski is the co-founder and CEO of WearLinq and a member of Forbes’ 30 under 30 list. His company developed an FDA-cleared EKG monitor, eWave, which provides continuous cardiac monitoring for weeks at a time. WearLinq also connects patients to virtual cardiologists offering diagnoses and referrals, making it particularly valuable for patients in rural or underserved areas. In this interview, Konrad shares how he optimizes fundraising efforts by aligning them with important milestones, his unconventional methods to gather voice of customer research, and how his startup moved rapidly through product design iterations.

Premium

Validating Demand in Medtech

Interview with Pristine Surgical CEO Bryan Lord

Under Bryan Lord’s leadership, Pristine Surgical has developed Summit, a fully integrated single-use, digital arthroscope with 4K resolution. In this interview, Bryan shares the story of how he evolved his career to become a medtech entrepreneur and the lessons he learned along the way—about how to protect your competitive advantage, how to achieve market pull vs. market push, and the importance of collaborating with experienced mentors.

Premium

Managing Critical Risks in Early-Stage Medtech

Interview with Instylla CEO Amarpreet Sawhney

Amarpreet Sawhney has developed advanced biosurgery technologies, leading to several FDA-approved products, including surgical sealants, spacers, and drug delivery systems. Today, he is the CEO of a few companies, including Instylla, which is developing polymerizing liquid embolics. These embolics can be used to shut down the blood supply to hypervascular tumors and control bleeding by occluding damaged or problematic blood vessels. In this episode, Amar shares his frameworks on risk assessment for medtech startups, tips on clinical study design, and how to prioritize indications when working on platform technologies.

Premium

Get exclusive benefits like full access to the entire archive of Medsider interviews and every Medsider Mentors volume.

Go Premium
Premium

Build for the User, Not the Spec Sheet

Interview with Phagenesis CEO Reinhard Krickl

Under the leadership of Reinhard Krickl, Phagenesis is commercializing a neurostimulation system designed to treat dysphagia, a condition that impairs a patient's ability to swallow and prevents complications like malnutrition and aspiration pneumonia. In this interview, Reinhard shares insights on the importance of simplicity in design, what thorough market understanding truly means, and how he engages with stakeholders effectively. He also reveals the “market access checklist” he uses before entering the commercialization stage.

Premium

A Stage-Appropriate Framework for Startups

Interview with Cherish CEO Sumit Nagpal

Sumit Nagpal is a digital health veteran who was inspired by Steve Jobs himself to become an entrepreneur. He’s now founder and CEO of Cherish Health, a company that develops intelligent radar-based sensor platforms to support proactive self-care for the elderly, frail, and those with chronic conditions. In this interview, Sumit shares his take on the importance of being stage-appropriate—both mentally and business-wise—and how to recognize patterns in the market by simply listening. Oh - and constantly learn from others because, as Steve Jobs paraphrasing Picasso put it, “great artists steal.”

Premium

Forging Win-Win Collaborations in Healthcare

Interview with Reimagine Care CEO Dan Nardi

Dan Nardi is known for his operational expertise, understanding of value-based care, and success in building high-performing teams. Today, as the CEO of Reimagine Care, he’s working to extend cancer care beyond the clinic, giving patients a break from the arduous treatment journey, and alleviating the strain on caregivers, clinical teams, and the broader healthcare system. In this interview, Dan shares how he forms strategic partnerships that prioritize long-term value over short-term gains, how to leverage early adopters, and how he’s positioned his company in the emerging fee-for-value healthcare model.

Premium

How to Build a Community of Investors

Interview with Pirouette Medical CEO Conor Cullinane

Conor Cullinane is an aeronautical engineer with an impressive resume that spans MIT, Harvard, and NASA. He’s the co-founder and CEO of Pirouette Medical, a startup developing a low-profile, disc-shaped injector designed to deliver medicines more easily and effectively. In this interview, Conor shares learnings from launching a community fundraising round, insights on selective innovation, identifying different value propositions for diverse stakeholders, and building strong investor relationships.

Premium

A Physician's Guide to Turning Ideas into Reality

Interview With Canary Medical CEO Dr. Bill Hunter

Dr. Bill Hunter, CEO of Canary Medical, is an accomplished entrepreneur who’s been intimately involved in the development of renowned devices like the TAXUS drug-eluting coronary stent, the paclitaxel-eluting balloon, the Zilver PTX peripheral drug-eluting stent, and the Quill barbed wound closure device. For over a decade, Bill and his team at Canary have developed smart, implantable medical devices that report on function, patient activity, and more. In this interview, Bill talks about his perspective on innovation in medtech, discusses what it takes for a device to be commercially viable, how Canary is alleviating the workload of healthcare professionals, and offers advice to physicians contemplating the transition to industry.

Premium

Silicon Valley Approach to Medtech

Interview with Oncoustics CEO Beth Rogozinski

Leveraging her extensive experience in digital medicine, Beth Rogozinski leads Oncoustics, a company that uses advanced AI to analyze ultrasound data to offer a cost-effective alternative to traditional diagnostic methods. In this interview, Beth shares her insights on the importance of persistence and resilience in fundraising, the value of engaging with a diverse range of investors, and the need for a strong narrative about your technology, particularly when it involves AI capabilities.

Premium

Proof Before Funding

Interview with VenoStent CEO and COO, Tim Boire and Geoffrey Lucks

VenoStent is developing SelfWrap, a bioabsorbable wrap to improve the success rate of vascular surgeries, starting with dialysis access creation for chronic kidney disease (CKD) patients. In this Interview, co-founders Geoffrey Lucks and Timothy Boire share the challenges and triumphs of their journey toward bringing this innovative product to market. We talk about understanding your end user, working collaboratively with FDA, structuring and executing large clinical trials, and staying resourceful to attract funding while developing your concept.

Premium

A Roadmap for Proving Clinical Efficacy and Economic Value

Interview with Mainstay Medical CEO Jason Hannon

Mainstay Medical has developed the first restorative neurostimulation treatment that alleviates chronic mechanical back pain. In this interview, Jason Hannon, the CEO and President of the company, shares his experiences on iterative product development, considerations for clinical trial design, the importance of patient education, and why reimbursement is paramount.